Cost-effectiveness of CTC guided chemo- or endocrine therapy in ER+ HER2- metastatic breast cancer – results from a randomized controlled multicenter trial
Sofie Berghuis, Erik Koffijberg, Xavier Pouwels, Frederique Berger, Catherine Alix-Panabieres, William Jacob, Jan-Yves Pierga, Francois-Clement Bidard, Maarten IJzerman*
Research output: Working paper › Preprint › Academic
64Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Cost-effectiveness of CTC guided chemo- or endocrine therapy in ER+ HER2- metastatic breast cancer – results from a randomized controlled multicenter trial'. Together they form a unique fingerprint.